...
search icon
kod-img

Kodiak Sciences Inc Share Price

KOD
NMQ
$21.94
-$0.06
(-0.27%)
1D
Industry: Biotechnology Sector: Health Care

Kodiak Sciences Inc Analyst Forecast

Kodiak Sciences Inc Share Price Chart

Kodiak Sciences Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.34B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
197.12K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.65
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.92 L
$31.18 H
$21.94

About Kodiak Sciences Inc, Common Stock

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), an unconjugated bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California. more

Industry: BiotechnologySector: Health Care

Kodiak Sciences Inc Stock Returns

Time FrameKODSectorS&P500
1-Week Return4.71%0.75%0.54%
1-Month Return-21.6%-0.88%-2.01%
3-Month Return8.64%2.08%-0.28%
6-Month Return158.22%18.91%6.04%
1-Year Return340.88%6.98%12.92%
3-Year Return204.71%16.78%65.15%
5-Year Return-85.99%33.02%73.52%
10-Year Return116.54%142.35%266.07%

Kodiak Sciences Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue4.21M8.71M11.00M25.95M26.71M[{"date":"2020-12-31","value":15.76,"profit":true},{"date":"2021-12-31","value":32.62,"profit":true},{"date":"2022-12-31","value":41.19,"profit":true},{"date":"2023-12-31","value":97.16,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(4.21M)(8.71M)(11.00M)(25.95M)(26.71M)[{"date":"2020-12-31","value":-420800000,"profit":false},{"date":"2021-12-31","value":-871100000,"profit":false},{"date":"2022-12-31","value":-1100100000,"profit":false},{"date":"2023-12-31","value":-2594700000,"profit":false},{"date":"2024-12-31","value":-2670600000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses131.80M258.34M330.38M251.37M160.14M[{"date":"2020-12-31","value":39.89,"profit":true},{"date":"2021-12-31","value":78.2,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":76.09,"profit":true},{"date":"2024-12-31","value":48.47,"profit":true}]
Operating Income(136.01M)(267.05M)(341.38M)(277.32M)(186.85M)[{"date":"2020-12-31","value":-13600700000,"profit":false},{"date":"2021-12-31","value":-26705100000,"profit":false},{"date":"2022-12-31","value":-34137900000,"profit":false},{"date":"2023-12-31","value":-27732100000,"profit":false},{"date":"2024-12-31","value":-18684900000,"profit":false}]
Total Non-Operating Income/Expense5.79M337.00K14.61M33.55M21.79M[{"date":"2020-12-31","value":17.25,"profit":true},{"date":"2021-12-31","value":1,"profit":true},{"date":"2022-12-31","value":43.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":64.95,"profit":true}]
Pre-Tax Income(133.10M)(266.99M)(333.82M)(260.49M)(176.21M)[{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false},{"date":"2024-12-31","value":-17620700000,"profit":false}]
Income Taxes2.73M(153.56K)7.35M--[{"date":"2020-12-31","value":37.16,"profit":true},{"date":"2021-12-31","value":-2.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(135.83M)(266.84M)(341.17M)--[{"date":"2020-12-31","value":-13582570300,"profit":false},{"date":"2021-12-31","value":-26683644200,"profit":false},{"date":"2022-12-31","value":-34116851500,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(133.10M)(266.99M)(333.82M)(260.49M)(176.21M)[{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false},{"date":"2024-12-31","value":-17620700000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(133.10M)(266.99M)(333.82M)(260.49M)(176.21M)[{"date":"2020-12-31","value":-13309600000,"profit":false},{"date":"2021-12-31","value":-26699000000,"profit":false},{"date":"2022-12-31","value":-33382300000,"profit":false},{"date":"2023-12-31","value":-26049100000,"profit":false},{"date":"2024-12-31","value":-17620700000,"profit":false}]
EPS (Diluted)(2.89)(5.15)(6.39)(4.96)(3.36)[{"date":"2020-12-31","value":-289,"profit":false},{"date":"2021-12-31","value":-515,"profit":false},{"date":"2022-12-31","value":-639,"profit":false},{"date":"2023-12-31","value":-496,"profit":false},{"date":"2024-12-31","value":-336,"profit":false}]

Kodiak Sciences Inc Ratios

Kodiak Sciences Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

KOD
Cash Ratio 1.70
Current Ratio 1.78

Kodiak Sciences Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KOD
ROA (LTM) -47.21%
ROE (LTM) -207.92%

Kodiak Sciences Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KOD
Debt Ratio Lower is generally better. Negative is bad. 0.89
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.11

Kodiak Sciences Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KOD
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 59.03
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Kodiak Sciences Inc share price today?

Kodiak Sciences Inc (KOD) share price today is $21.94

Can Indians buy Kodiak Sciences Inc shares?

Yes, Indians can buy shares of Kodiak Sciences Inc (KOD) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KOD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kodiak Sciences Inc be purchased?

Yes, you can purchase fractional shares of Kodiak Sciences Inc (KOD) via the Vested app. You can start investing in Kodiak Sciences Inc (KOD) with a minimum investment of $1.

How to invest in Kodiak Sciences Inc shares from India?

You can invest in shares of Kodiak Sciences Inc (KOD) via Vested in three simple steps:

  • Click on Sign Up or Invest in KOD stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kodiak Sciences Inc shares
What is Kodiak Sciences Inc 52-week high and low stock price?

The 52-week high price of Kodiak Sciences Inc (KOD) is $31.18. The 52-week low price of Kodiak Sciences Inc (KOD) is $1.92.

What is Kodiak Sciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Kodiak Sciences Inc (KOD) is

What is Kodiak Sciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kodiak Sciences Inc (KOD) is 59.03

What is Kodiak Sciences Inc dividend yield?

The dividend yield of Kodiak Sciences Inc (KOD) is 0.00%

What is the Market Cap of Kodiak Sciences Inc?

The market capitalization of Kodiak Sciences Inc (KOD) is $1.34B

What is Kodiak Sciences Inc's stock symbol?

The stock symbol (or ticker) of Kodiak Sciences Inc is KOD

How Can Investors Use Kodiak Sciences Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Kodiak Sciences Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Kodiak Sciences Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Kodiak Sciences Inc shares for Indian investors?

When investing in Kodiak Sciences Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Kodiak Sciences Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Kodiak Sciences Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Kodiak Sciences Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Kodiak Sciences Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top